Abstract:BACKGROUND:RAB7A (RAS-related in Brain 7A) is an important member of the RAS oncogene family. However, the correlation between RAB7A and the development and immune infiltration of hepatocellular carcinoma (HCC) has rarely been studied. Here, we studied the role of RAB7A in HCC through bioinformatics analysis, real-world cohort validation, and in vitro experimental exploration.MATERIALS AND METHODS:The RAB7A expression level was analyzed through TCGA, HPA and TISIDB databases. TIMER and TISCH were used to analyze the correlation between RAB7A and tumor immune microenvironment. The expression of RAB7A was detected through real-time PCR and western blotting. The cell proliferation was detected by EdU and CCK8. Wound-healing and transwell assays were used to test the invasion and migration ability. Cell cycle distribution and reactive oxygen species (ROS) content were analyzed by flow cytometry. Identification of epithelial-mesenchymal transition (EMT) was performed by immunofluorescence double staining. Immunohistochemistry (IHC) was used to evaluate the correlation between RAB7A and immune checkpoints.RESULTS:RAB7A is upregulated in most of the tumor types, and the upregulation of RAB7A is associated with a poorer prognosis in many cancers. The results showed that RAB7A was significantly positively correlated with the infiltration of macrophages and cancer-associated fibroblasts (CAFs), but negatively correlated with M2-type macrophages in most tumors. The single-cell atlas also revealed the distribution and proportion of RAB7A in immune cells of HCC. The in vitro experiments suggested that RAB7A was increased in HCC tissue and cell lines. The knockdown of RAB7A inhibited the activation of the PIK3CA-AKT pathway and suppressed the expression of CDK4, CDK6 and CCNA2. Knockdown of RAB7A induced G0/G1 arrest and ROS accumulation in HCC. In addition, overexpression of RAB7A enhanced migration and invasion by inducing EMT. The real-world cohort showed that the expression level of RAB7A was positively correlated with the expression levels of TGFBR1 and PD-L1.CONCLUSIONS:RAB7A may serve as a potential tumor prognostic and immune infiltration-related biomarker, predicting immunotherapy efficacy in certain cancer types, especially in HCC. Besides, RAB7A was a multi-pathway target involved in the malignant progression of HCC.

Role of Rab GTPases in Hepatocellular Carcinoma

[Role of Wnt/β-catenin Signaling Pathway in Promoting Tumorigenesis of Hepatocellular Carcinoma].

RHO GTPase family in hepatocellular carcinoma

Lipophagy-related Gene RAB7A is Involved in Immune Regulation and Malignant Progression in Hepatocellular Carcinoma.

Function and regulation of Rab GTPases in cancers

Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer

Rab3B Proteins: Cellular Functions, Regulatory Mechanisms, and Potential as a Cancer Therapy Target

Ras-Related Protein Rab24 is a Predictor for Hepatocellular Carcinoma Prognosis and Promotes Tumor Growth

Identification And Characterization Of Nine Novel Human Small Gtpases Showing Variable Expression In Liver Cancer Tissues

Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma

RAB10 Overexpression Promotes Tumor Growth and Indicates Poor Prognosis of Hepatocellular Carcinoma.

RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells

The Prognostic Biomarker RAB7A Promotes Growth and Metastasis of Liver Cancer Cells by Regulating Glycolysis and YAP1 Activation

Rab11a Regulates MMP2 Expression by Activating the PI3K/AKT Pathway in Human Hepatocellular Carcinoma Cells.

RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance

RABIF promotes hepatocellular carcinoma progression through regulation of mitophagy and glycolysis

Targeting Rabs As a Novel Therapeutic Strategy for Cancer Therapy.

O-GLCNACYLATION ON RAB3A ATTENUATES ITS EFFECTS ON MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION AND METASTASIS IN HEPATOCELLULAR CARCINOMA

RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway

Hepatitis B Virus X Protein-Mediated Non-Coding RNA Aberrations in the Development of Human Hepatocellular Carcinoma